These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 31736378)

  • 41. Sociodemographic and clinical correlates of key outcomes from a Mobile Insulin Titration Intervention (MITI) for medically underserved patients.
    Langford AT; Wang B; Orzeck-Byrnes NA; Aidasani SR; Hu L; Applegate M; Moloney DN; Sevick MA; Rogers ES; Levy NK
    Patient Educ Couns; 2019 Mar; 102(3):520-527. PubMed ID: 30293934
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Can community retail pharmacist and diabetes expert support facilitate insulin initiation by family physicians? Results of the AIM@GP randomized controlled trial.
    Harris SB; Gerstein HC; Yale JF; Berard L; Stewart J; Webster-Bogaert S; Tompkins JW
    BMC Health Serv Res; 2013 Feb; 13():71. PubMed ID: 23433347
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Intuitiveness, instruction time, and patient acceptance of a prefilled insulin delivery device and a reusable insulin delivery device in a randomized, open-label, crossover handling study in patients with type 2 diabetes.
    Reimer T; Hohberg C; Pfützner AH; Jørgensen C; Jensen KH; Pfützner A
    Clin Ther; 2008 Dec; 30(12):2252-62. PubMed ID: 19167585
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A pilot study to examine the feasibility of insulin glargine in subjects with impaired fasting glucose, impaired glucose tolerance or new-onset type 2 diabetes.
    Marbury TC; Schwartz S; Rosenberg MA; Jariwala N; Becker RH; Johnston PS
    Exp Clin Endocrinol Diabetes; 2008 May; 116(5):282-8. PubMed ID: 18484560
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of Bromocriptine-QR Therapy on Glycemic Control and Daily Insulin Requirement in Type 2 Diabetes Mellitus Subjects Whose Dysglycemia Is Poorly Controlled on High-Dose Insulin: A Pilot Study.
    Roe ED; Chamarthi B; Raskin P
    J Diabetes Res; 2015; 2015():834903. PubMed ID: 26060825
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Telemedicine and diabetes: achievements and prospects.
    Franc S; Daoudi A; Mounier S; Boucherie B; Dardari D; Laroye H; Neraud B; Requeda E; Canipel L; Charpentier G
    Diabetes Metab; 2011 Dec; 37(6):463-76. PubMed ID: 21889388
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The Digital/Virtual Diabetes Clinic: The Future Is Now-Recommendations from an International Panel on Diabetes Digital Technologies Introduction.
    Phillip M; Bergenstal RM; Close KL; Danne T; Garg SK; Heinemann L; Hirsch IB; Kovatchev BP; Laffel LM; Mohan V; Parkin CG; Battelino T
    Diabetes Technol Ther; 2021 Feb; 23(2):146-154. PubMed ID: 32905711
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Real-World Effectiveness of the Gla-300 + Cap + App Program in Adult Users Living with Type 2 Diabetes in Taiwan.
    Wang CY; Zhou FL; Gandhi AB; Lee TY; Cui N; Mao JS; Chen JF
    Diabetes Ther; 2024 Jun; 15(6):1389-1401. PubMed ID: 38642260
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Experience Sampling and Programmed Intervention Method and System for Planning, Authoring, and Deploying Mobile Health Interventions: Design and Case Reports.
    Cunha BCR; Rodrigues KRDH; Zaine I; da Silva EAN; Viel CC; Pimentel MDGC
    J Med Internet Res; 2021 Jul; 23(7):e24278. PubMed ID: 34255652
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of Effectiveness and Psychological Techniques Implemented in mHealth Solutions for Middle-Aged and Elderly Adults with Type 2 Diabetes: A Narrative Review of the Literature.
    Vázquez-de Sebastián J; Ciudin A; Castellano-Tejedor C
    J Clin Med; 2021 Jun; 10(12):. PubMed ID: 34207402
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Dosing of insulin glargine in the treatment of type 2 diabetes.
    Barnett A
    Clin Ther; 2007 Jun; 29(6):987-99. PubMed ID: 17692716
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The effect of an mHealth intervention for titration of insulin for type 2 diabetes: A pilot study.
    Bramwell SE; Meyerowitz-Katz G; Ferguson C; Jayaballa R; McLean M; Maberly G
    Eur J Cardiovasc Nurs; 2020 Jun; 19(5):386-392. PubMed ID: 31736378
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transition of a Text-Based Insulin Titration Program From a Randomized Controlled Trial Into Real-World Settings: Implementation Study.
    Levy NK; Orzeck-Byrnes NA; Aidasani SR; Moloney DN; Nguyen LH; Park A; Hu L; Langford AT; Wang B; Sevick MA; Rogers ES
    J Med Internet Res; 2018 Mar; 20(3):e93. PubMed ID: 29555621
    [TBL] [Abstract][Full Text] [Related]  

  • 54. User Experience of an Innovative Mobile Health Program to Assist in Insulin Dose Adjustment: Outcomes of a Proof-Of-Concept Trial.
    Ding H; Fatehi F; Russell AW; Karunanithi M; Menon A; Bird D; Gray LC
    Telemed J E Health; 2018 Jul; 24(7):536-543. PubMed ID: 29261476
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Mobile Insulin Titration Intervention (MITI) for Insulin Adjustment in an Urban, Low-Income Population: Randomized Controlled Trial.
    Levy N; Moynihan V; Nilo A; Singer K; Bernik LS; Etiebet MA; Fang Y; Cho J; Natarajan S
    J Med Internet Res; 2015 Jul; 17(7):e180. PubMed ID: 26187303
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Implementation of telehealth support for patients with type 2 diabetes using insulin treatment: an exploratory study.
    Turner J; Larsen M; Tarassenko L; Neil A; Farmer A
    Inform Prim Care; 2009; 17(1):47-53. PubMed ID: 19490773
    [TBL] [Abstract][Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.